From: Trends in suicide mortality among prostate cancer survivors in the United States, 1975–2019
SMR | 95%CI | |
---|---|---|
Overall | 1.15 | 1.09–1.2* |
Calendar year of diagnosis | ||
1975–1979 | 1.74 | 1.17–2.51* |
1980–1984 | 1.41 | 1.08–1.8* |
1985–1989 | 2.01 | 1.72–2.34* |
1990–1994 | 1.56 | 1.35–1.78* |
1995–1999 | 1.18 | 1.02–1.35* |
2000–2004 | 1.1 | 0.96–1.25 |
2005–2009 | 0.98 | 0.86–1.11 |
2010–2014 | 0.98 | 0.88–1.1 |
2015–2019 | 0.99 | 0.89–1.1 |
Ptrend (Coefficient) | < 0.001 (-0.091) | |
SMR | 95%CI | |
Age at diagnosis (year) | ||
45–49 | 0.72 | 0.2–1.85 |
50–54 | 0.94 | 0.6–1.41 |
55–59 | 0.96 | 0.74–1.23 |
60–64 | 0.98 | 0.81–1.18 |
65–69 | 1.16 | 1.01–1.33* |
70–74 | 1.24 | 1.11–1.38* |
75–79 | 1.13 | 1.01–1.25* |
80–84 | 1.16 | 1.04–1.29* |
85+ | 1.20 | 1.08–1.33* |
Ptrend (Coefficient) | 0.078(0.023) | |
SMR | 95%CI | |
Latency after PCa diagnosis (month) | ||
0–11 | 1.26 | 1.09–1.46* |
12–59 | 1.11 | 1.02–1.2* |
60–119 | 1.17 | 1.07–1.27* |
120+ | 1.13 | 1.04–1.24* |
Ptrend (Coefficient) | 0.599(-0.012) |